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This study was undergone to evaluate the in-vivo anti-hyperglycemic and antioxidant potential of ethanolic extract
of leaves of Tecomella undulata Seem. on streptozotocin-nicotinamide induced type 2 diabetic rats. Type 2 diabetes
was induced by single intraperitoneal injection (i.p.) of 60 mg/kg streptozotocin, 15 minutes after the i.p
administration of 110 mg/kg body weight of nicotinamide. The extract has shown significant blood glucose
lowering effect in the oral glucose tolerance test (OGTT). The blood glucose level, cholesterol, glycogen contents,
glycosylated hemoglobin, and antioxidant parameters (Malondialdehyde and Glutathione level) were estimated
from the blood plasma by using standard kits to demonstrate the hypoglycemic and antioxidant effect in treated
animals. The data showed that the extract have significant influence on the above biochemical parameters. Thus
ethanolic fraction of the plant Tecomella undulata can be used as new candidate for antihyperglycemic and
antioxidant.
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Diabetes mellitus is a common disorder of carbohydrate,
fat, and protein metabolism in which the circulating
glucose concentration is increased and it causes compli-
cations such as retinopathy, microangiopathy, neur-
opathy and nephropathy [1]. This is a chronic incurable
condition due to insulin deficiency or lesser action or
both that affect 10% of the population [2]. Currently
diabetes affects 150 million people worldwide and this is
likely to increase to 300 million by the year 2025 [3]. It
has been estimated that diabetic patients in India are
expected to increase 57.2 million by the year 2025 [4].
There are a lot of synthetic derivatives which are used in
the treatment of diabetes. But now days, there are in-
crease interest in herbal agents as therapeutic treatment
due to their limited adverse effects [5-7].
In India, family Bignoniaceae is represented by 21
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reproduction in any medium, provided the orornamental plants. The genera of Tecomella are a mono-
typic genus shrub/tree of the arid zone region in India.
The plant Tecomella undulata Seem. (Bignoniaceae) is
commonly known as desert teak or Rohida. The species
has been identified as an important for environmental
conservation in arid zones as a stabilizer of shifting sand
dunes, providing shelter for wild life. It is also a very useful
species for afforestation of the drier tracts due to its
drought and fire resistant properties [8]. It occurs on flat
and undulating areas including gentle hill slopes and
sometimes also ravines and thrives very well on stabilized
sand dunes, which experience extreme low and high
temperature. It plays an important role in ecology; it acts
as a soil binding tree by spreading a network of lateral
root on the tops surface of the soil. The tree is propagated
from seeds or cutting and succeeded well in drained
fibrous land [9]. It is a common agro forestry tree species
in the Thar Desert of Rajasthan for its higher survival rates
even in extreme drought conditions [10]. It has a signifi-
cant anticancer, hepatoprotective [11], analgesic [12] and
antibacterial activity [13,14]. The plant contains the major
constituents like tecomine, β-sitosterols, chromones gly-
cosides, undulatosides, tecomellosides, tecosides lapacholLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the treatment of diabetes but the scientific reports are not
available till date. So the work has planned to prove scien-
tifically that the plant is used to combat this metabolic dis-
order for the welfare of the society.Materials and methods
Drugs and chemicals
Drugs used in the present study were procured from dif-
ferent sources as shown: Metformin (Ranbaxy Labs,
Gurgaon, India), streptozotocin, heparin (SRL, Mumbai,
India), EDTA (Hi-media Lab. Pvt Ltd., Mumbai, India),
n-butanol, acetic acid, n-hexane, petroleum ether, ethyl
acetate, glucose standard, citric acid, sodium citrate, tris
hydrochloride, buffer tablet, sodium lauryl sulphate,
thiobarbituric acid, trichloroacetic acid, triton-X, glyco-
gen, ethanol, Tween 80, carboxymethyl cellulose, Ell-
man’s reagent (5,5’-dithiobis-(2-nitro-benzoic acid);
DTNB), sodium sulphate, methanol, pyridine, anthrone,
thiourea, benzoic acid, sodium chloride (SD Fine Chem
Ltd., Mumbai, India).Preparation of plant extract
The leaves of Tecomella undulata was collected from
the local fields of Shekhawati area of Rajasthan (India)
and identified by Dr. H. B. Singh, Head, Raw Materials
Herbarium and Museum, National Institute of Science
Communication and Information Resources (NISCAIR),
India (NISCAIR/RHMD/Consult/-2011-12/1767/67).
The leaves were dried at 40 ± 1°C, grounded into a
granulated powder and defatted with petroleum ether.
The ethanolic extract was obtained by extracting 2 kg of
leaves powder macerated with ethanol (95%) at 25°C for
7 days followed by filtration and concentrated in water
bath. All the extract was stored at temperature below
10°C and freshly prepared with 2% Tween 80 for
pharmacological experiments.Experimental animals
Albino wistar rats (Body Weight 150-250 g) were pro-
cured from Disease Free Small Animal House, Lala Laj-
pat Rai Veterinary University, Hisar (Haryana), India.
The rats were housed in cages (Polycarbonate cage size:
29 × 22 × 14 cm) under laboratory conditions with alter-
nating light and dark cycle of 12 h each. The animals
had free access to food and water. The animals were
kept fasted 2 h before and 2 h after drug administration.
The experimental protocol was approved by Institutional
Animals Ethics Committee (IAEC) and animal care was
taken as per the guidelines of Committee for the Pur-
pose of Control and Supervision of Experiments on Ani-
mals (CPCSEA), Govt. of India (Registration No. 0436).Induction of diabetes
The type-2 diabetes mellitus (NIDDM) was induced in
overnight fasted animals by a single intraperitoneal in-
jection of 60 mg/kg streptozocin, 15 minute after the i.p.
administration of 110 mg/kg nicotinamide. Hypergly-
cemia was confirmed by the elevated blood glucose
levels determined at 72 hour then on 7th day of the in-
jection. Only rats confirmed with permanent NIDDM
(Glucose level above 250 mg/dl) were used in the anti-
diabetic study [18].
Experimental design
Rata were divided into five groups comprising six rats in
each group after the induction of diabetes.
Group 1 Normal control rats administered 2% Tween
80
Group 2 Diabetic control rats administered 2% Tween
80
Group 3 Diabetic animals were administered
metformin (100 mg/kg; p. o.)
Group 4 and 5 Diabetic animal were administered
orally 200 mg/kg p.o. and 500 mg/kg p. o. ethanolic
extract of Tecomella undulata leaves respectively
Sample collection
Blood sample
The 24 h fasted animals were sacrificed by cervical de-
capitation on 30 th day of treatment. Trunk blood was
collected in heparinized tubes and the plasma was
obtained by centrifugation at 5000 rpm for 5 minutes. It
was used for the determination of biochemical para-
meters like plasma glucose, cholesterol, malondialdehyde
(MDA), reduced glutathione etc. While whole blood was
used for glycosylated hemoglobin.
Collection of organs
The rats were euthanized by using the overdose of intra-
peritoneal anesthesia, and tissue sample were taken for
assessment of biochemical parameters.
Estimation of plasma glucose and cholesterol
Plasma cholesterol and glucose level were measured by
commercial supplied biological kit Erba Glucose Kit
(GOD-POD Method) and Erba Cholesterol Kit (CHOD-
PAP Method) respectively using Chem 5 Plus-V2 Auto-
analyser (Erba Mannhein Germany) in plasma sample
prepared as above. Glucose and cholesterol values were
calculated as mg/dl blood sample.
Estimation of glycosylated hemoglobin (Hb1Ac)
Glycosylated hemoglobin was measured using commer-
cial supplied biological kit (Erba Diagnostic) in plasma
sample prepared as above using Chem 5 Plus-V2 Auto-
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expressed as the percent of total hemoglobin.
Estimation of MDA level
Malondialdehyde (MDA), an index of free radical gener-
ation/lipid peroxidation, was determined as described by
Okhawa et al. 1979 [19]. Briefly, the reaction mixture
consisted of 0.2 ml of 8.1% sodium lauryl sulphate,
1.5 ml of 20% acetic acid (pH 3.5) and 1.5 ml of 0.8%
aqueous solution of thiobarbituric acid added to 0.2 ml
of blood plasma. The mixture was made up to 4.0 ml
with distilled water and heated at 95°C for 60 min. After
cooling the contents under running tap water, 5.0 ml of
n-butanol and pyridine (15:1 v/v) and 1.0 ml of distilled
water was added. The contents were centrifuged at
about 3000 rpm for 10 min. The organic layer was sepa-
rated out and its absorbance was measured at 532 nm
using double beam UV-Visible spectrophotometer
(Systronics 2203, Bangalore, India) against a blank.
MDA values are calculated using the extinction coeffi-
cient of MDA-thiobarbituric acid complex 1.56 × 105
l/mol × cm and expressed as nmol/ml [19].
Estimation of plasma reduced glutathione level
The tissue sample (Liver 200 mg) was homogenized in
8.0 mL of 0.02 M EDTA in an ice bath. The homogenates
were kept in the ice bath until used. Aliquots of 5.0 mL of
the homogenates were mixed in 15.0 mL test tubes with
4.0 mL distilled water and 1.0 mL of 50% trichloroacetic
acid (TCA). The tubes were centrifuged for 15 min at ap-
proximately 3000× g, 2.0 mL of supernatant was mixed
with 4.0 mL of 0.4 M Tris buffer pH 8.9, 0.1 mL Ellman’s
reagent [5,5-dithiobis-(2-nitro-benzoic acid)] (DTNB)
added and the sample shaken. The absorbance was read
within 5 min of the addition of DTNB at 412 nm against a
reagent blank with no homogenate. Results were expressed
as μmol GSH/g tissue [20].
Estimation of liver glycogen content
Liver glycogen estimation was done by the method as
described by Seifter et al. [21] Immediately after excision
from the animal, 1 g of the liver was dropped into a pre-
viously weighed test tube containing 3 ml of 30%Table 1 Acute hypoglycemic effect of Tecomella undulata on
Treatment Dose Mean blood glucose
0 hr 1/2
Control ————————— 75.1 ± 3.6 97
Metformin 100 mg/kg 83.7 ± 2.1 78
TU Eth. 200 mg/kg 74.3 ± 2.3 98
TU Eth. 500 mg/kg 76.6 ± 4.1 98
Values are presented as mean ± S.E.M. n = 6 in each group. One way ANOVA follow
of Tecomella undulata leaf.potassium hydroxide solution. The weight of the liver
sample was determined. The tissue was then digested by
heating the tube for 20 min in boiling water bath, and
following this the digest was cooled, transferred quanti-
tatively to a 50 ml volumetric flask, and diluted to the
mark with water. The contents of the flask were then
thoroughly mixed and a measured portion was then fur-
ther diluted with water in a second volumetric flask so
as to yield a solution of glycogen of 3–30 μg/ml. Five ml
aliquots of the final dilution were then pipette into Eve-
lyn tube and the determination with anthrone was car-
ried out. The amount of glycogen in the aliquot used
was then calculated using the following equation:
μg of glycogen in a liquot ¼ 100U=1:11S
U is the optical density of unknown solution. S is the
optical density of the 100 μg glucose and 1.11 is the fac-
tor determined by Morris in 1948 for the conversion of
the glucose to the glycogen [21].
Statistical analysis
The data for various biochemical parameters were evalu-
ated by use of one- way ANOVA, followed by Dunnett
test using the software Sigma-Stat 3.5. In all the tests,
the criterion for statistical significance was p <0.05.
Results
Acute hypoglycaemic effect of Tecomella undulata on
normoglycaemic rats
The effect of the treatment with Tecomella undulata leaf
extract on the plasma glucose in normal fasted rats is
shown in Table 1. None of the tested doses presented
any significant lowering of blood glucose when com-
pared to the control animals at different time intervals
at different doses.
Acute hypoglycemic effect of Tecomella undulata on STZ
induced diabetic rats
In the acute study of Tecomella undulata 200 mg/kg b.
wt p.o. to STZ diabetic rats showed a fall in plasma glu-
cose level from 385 mg/dl to 346 mg/dl at 4th hour when
compared to 0 days value. At a dose of 500 mg/kg b.wtnormoglycaemic rats
concentration (mg/dl) ± S.E.M
hr 1 hr 2 hr 4 hr
.4 ± 2.5 141 ± 2.8 111 ± 2.9 82.7 ± 2.5
.7 ± 4.2* 105 ± 3.4** 72.3 ± 2.4** 64.4 ± 4.7**
.4 ± 1.4 134 ± 5.0 91.6 ± 4.8 86.3 ± 3.7
.7 ± 6.0 138.8 ± 4.4 124.3 ± 6.4 85.3 ± 2.6
ed by Dunnett’s t test *p< 0.05,**p< 0.01 vs. control TU Eth.: Ethanolic extract
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from 379 mg/dl to 339 mg/dl at 4th hour (p< 0.001).
Chronic hypoglycemic effect of Tecomella undulata on
STZ induced diabetic rats
In the chronic study of Tecomella undulata 200 mg/kg
b.wt orally to STZ diabetic rats for 30 days showed a fall
in plasma glucose level from 383.1 mg/dl to 237 mg/dl
at 30th day when compared to 0 day value. At a dose of
500 mg/kg b.wt orally there was a significant fall in
plasma glucose level from 376 mg/dl to 185 mg/dl at
30th day (p< 0.001) (Table 2).
Effect of Tecomella undulata in glucose loaded
hyperglycaemic (OGTT) rats
The effect of Tecomella undulata extract on plasma glu-
cose level after glucose loading at 2 g/kg b.wt orally to
the normal, diabetic and test animal was expressed in
Figure 1. The blood glucose level rises to a maximum in
30 min after glucose loading. The extract treated groups
at both 200 mg/kg and 500 mg/kg b.wt showed a signifi-
cant increase in rate of clearance of glucose as compared
to untreated group. The extract treated group showed a
marked fall in glucose level in 30 min to 120 min inter-
val. After 120 min the plasma glucose level returns to
normal value.
Effect of Tecomella undulata on glycosylated hemoglobin
The data Presented in Figure 2 indicated the effect of
Tecomella undulata extract on glycosylated hemoglobin
(HbA1c). The HbA1c data for the STZ diabetic group
were significantly higher than the normal rats The
Chronic administration of the standard drug significantly
lowered the HbA1c in 30 days. The administration of
extracts produced a similar effect when compared to the
standard drug, metformin. Higher doses produced more
reduction HbA1c level.
Effect of Tecomella undulata on liver glycogen content
The liver glycogen level was found to be low in STZ rats
when compared to normal rats Tecomella undulata ex-
tract at the dose level 200 mg/kg and 500 mg/kg b.wtTable 2 Acute hypoglycemic effect of Tecomella undulata on
Treatment Dose Mean blood glucose c
0 hr
Control ————————— 385.5 ± 12 40
Metformin 100 mg/kg 393.4 ± 27.2
TU Eth. 200 mg/kg 385 ± 26.4 38
TU Eth. 500 mg/kg 379.8 ± 21.8 37
Values are presented as Mean ± S.E.M.; n = 6 in each group. One way ANOVA follow
Ethanolic extract of Tecomella undulata leaf.increased the liver glycogen content significantly when
compared diabetic control rats (Figure 3).
Effect of Tecomella undulata on antioxidant parameters
The plasma level of malondialdehyde (MDA) and
reduced glutathione (GSH) of normal and experimental
animal in each group is shown in Figures 4 & 5. Plasma
MDA level in plasma was significantly increased in STZ
diabetic rats compared to normal rats. Treatment of
STZ diabetic rats with Tecomella undulata resulted in
marked decrease in plasma level of MDA. The level of
MDA in diabetic rats treated with Tecomella undulata
was comparable to those in STZ diabetic rats treated
with metformin (Figure 4)
The plasma glutathione level was significantly
decreased in STZ rats compared to control animals
(Figure 5) the level of glutathione was returned to near
normal range in STZ diabetic rats treated with Teco-
mella undulata and metformin.
Discussion
The present study was conducted to access the antihy-
perglycemic and antioxidant activity of Tecomella undu-
lata leaves extract on STZ induced diabetic rats. STZ
diabetic model is widely used for elucidation of type 2
antidiabetic activity. In the case of acute antihyperglyce-
mic study, metformin has been selected as reference
drug being its ability to modulate the insulin secretion
independent of blood glucose concentration. The results
presented in Table 3 indicated that Tecomella undulata
extract produced antihyperglycemic activity in a dose de-
pendant manner. Further at a dose of 500 mg/kg b. wt
the extract produced significant antihyperglycemic activ-
ity when compared with the reference compound
metformin. Here the glucose lowering activity of Teco-
mella undulata may be attributed to both pancreatic
(enhancement of insulin secretion) and extra pancreatic
(peripheral utilization of glucose) mechanisms. Antihy-
perglycemic activity at lower dose (200 mg/kg) may be
due to anyone of the aforementioned mechanism.
On treatment for 30 days, Tecomella undulata not
only reduced the fasting blood glucose level but also
improved the glucose tolerance in STZ rats. TheSTZ induced diabetic rats
oncentration (mg/dl) ± S.E.M
2 hr 4 hr 6 hr 24 hr
4.8 ± 10.3 397.7 ± 5.6 379 ± 6.1 341 ± 7.1
342± 8.9 334± 7.9** 280.8 ± 6.9** 363 ± 5.2
1.1 ± 26.2 346 ± 23.4** 356± 29* 370 ± 2.3
6.2 ± 20.7 339.9 ± 22.3* 330± 1.6** 371 ± 9.4
ed by Dunnett’s t test, * p< 0.05, ** p< 0.01, *** p< 0.001 vs. control; TU Eth.:
Figure 1 Effect of ethanolic extract of leaves of Tecomella
undulata on glucose loaded hyperglycaemic (OGTT) rats. Values
are presented as Mean; n = 6 in each group. PG: Plasma Glucose; T.
alc: Ethanolic extract of Tecomella undulata leaf.
Figure 3 Effect of ethanolic extract of leaves of Tecomella
undulata on liver glycogen content. Values are presented as
mean± S.E.M; one way ANOVA followed by Dunnett test; b P< 0.01
when compared to normal animals, **P< 0.01 when compared to
diabetic control animals, Nor: Normal rats; Dia Cont: Diabetic control;
Met: Metformin (100mg/kg of body wt orally); TU: Tecomella
Undulata.
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cemia may be due to its extra pancreatic action and this
is supported by improved glucose tolerance. Elevated
glycosylated hemoglobin (HbAlc) was observed in the
diabetic control group (12.2 ± 1.18% of Hb) when com-
pared to normal rats (6.1 ± 0.75%) which was similar to
earlier reports [22]. High glycosylated hemoglobin level
indicates poor glycaemic control and responsible for the
development of diabetic complications viz. vascular dys-
function, neuropathy and diabetic nephropathy. In un-
controlled and long term diabetes, there is an increased
glycosylation of a number of proteins, including
hemoglobin. The level of HbAlc is monitored as a reli-
able index of glycaemic is control in diabetes. Increase
in non-enzymatic and auto-oxidative glycosylation is one
of the possible mechanism linking hyperglycemia and
complications of diabetes [23]. In case of diabetic rats
treated with Tecomella undulata extract (500 mg/kg, p.
o.), the HbAlc value was brought down from elevatedFigure 2 Effect of ethanolic extract of leaves of Tecomella
undulata on glycosylated hemoglobin (HbA1c). Values are
represented as mean± S.E.M. one way ANOVA followed by Dunnett
test; *p< 0.05, **P< 0.01 when compared to diabetic control
animals. Nor: Normal Rats; HbA1c: Glycosylated Hemoglobin; TU:
Tecomella Undulata.level (12.36 ± 0.91% of Hb) to almost normal (6.24 ± 0.38;
Figure 4).
Hepatic glycogen level was found to be low in diabetic
rats (22 ± 1.198 mg/g wt of tissue) when compared to
normal rats (58 ± 0.85 mg/g wt of tissue), which are
probably due to the results of altered insulin action in
diabetic state. Insulin activates the glycogen synthase
system [24]. The significant increase in the glycogen
level (p< 0.01) on treatment with extract (500 mg/kg)
may be due to the reactivation of glycogen synthase sys-
tem by Tecomella undulata.
Tecomella undulata leaves have reported to have both
in-vitro and in-vivo antioxidant potential but no scien-
tific reports are available till date in diabetic animals.
Increasing evidence in both experimental and clinical
studies suggested that oxidative stress plays a major role
in the development and progression of both type 1 and
type 2 diabetes mellitus. There has been considerableFigure 4 Effect of ethanolic extract of leaves of Tecomella
undulata on plasma malondialdehyde (MDA). Values are
presented as mean± S.E.M; one way ANOVA followed by Dunnett
test; b P< 0.01, when compared to normal group, *P< 0.05 when
compared to diabetic control animals; Nor: Normal rats; Dia Cont:
Diabetic control; Met: Metformin (100mg/kg of body wt orally); TU:
Tecomella Undulata.
Figure 5 Effect of ethanolic extract of leaves of Tecomella
undulata on plasma glutathione (GSH) level. Values are
presented as mean± S.E.M; one way ANOVA followed by Dunnett
test; a P< 0.05, b P< 0.01 when compared to normal group;
*P< 0.05, **P< 0.01 when compared to diabetic control animals;
Nor: Normal rats; Dia Cont: Diabetic control; Met: Metformin
(100mg/kg of body wt orally); TU: Tecomella Undulata, GSH: Reduced
Glutathione.
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oxidative stress contributes towards the development of
diabetic complication. The facts that the role of antioxi-
dant compound in both protection and therapy of dia-
betes mellitus were also emphasized in previous
scientific studies. There is an evidence that glycosylation
of various protein may itself induce the generation of
oxygen-derived free radicals in diabetic condition [25].
Hyperglycemia results in the generation of free radical
which can exhaust antioxidant defense thereby leading
to the disruption of cellular function, oxidative damage
to membrane and enhance the susceptibility to lipid per-
oxidation [26] and diffuse from the site of tissue damage
which is measured by malondialdehyde level. Fivefold
increases in plasma malondialdehyde level was observed
in diabetic rats (5.1 ± 0.71 nmcl/ml) compared to normal
rats (1.8 ± 0.23 nmol/ml) which is similar to earlier re-
port [27]. Tecomella undulata extract significantly
(p< 0.05) decreased lipid peroxidation in diabetic rats at
both 200 mg/kg and 500 mg/kg oral doses. The extract
at 500 mg/kg p. o. dose showed marked reduction in the
plasma MDA level (2.07 ± 0.50 nmol/ml) than referenceTable 3 Chronic hypoglycemic effect of Tecomella undulata o
Treatment Dose Mean blood gluc
1st day
Control ————————— 403.8 ± 13.3
Metformin 100 mg/kg 344 ± 9.9
TU Eth 200 mg/kg 383.1 ± 26.2
TU Eth 500 mg/kg 376.2 ± 20.7
Values are presented as Mean ± S.E.M.; n = 6 in each group. One way ANOVA follow
Ethanolic extract of Tecomella undulata leaf.antihyperglycemic drug metformin (2.47 ± 0.84 nmol/ml).
It can be postulated that marked reduction in plasma
MDA level is a result of both direct antioxidant action
and glycaemic control.
Decrease in the level of glutathione (GSH) in diabetic
rats (11.89 ± 0.987 mg/dl) compared to normal rats
(36.17 ± 1.205) give evidences for altered antioxidant
system during diabetes (Gupta et al., 1997). Reduced
glutathione has an important role in regulation of cellu-
lar redox state and therefore imbalance in reduced gluta-
thione to oxidized glutathione is a putative indicator of
cellular oxidative stress [28]. Decreased level of glutathi-
one in plasma of n-STZ diabetic rats was partly due to
its utilization by the tissue to compromise the deleteri-
ous effect of lipid peroxidation [29]. Tecomella undulata
extract (500 mg/kg p. o.) increased the level of GSH near
to normal 27.74 ± 3.68) in n-STZ diabetic rats, this may
be due to its direct antioxidant properties or its
increased glycaemic control. In the study, reduced glyco-
sylated hemoglobin level and improved glutathione level
in extract treated rats was observed and gives a negative
correlation between GSH and HbA1c in diabetic animal
as reported by Giugaliano et al., 1996, which confirmed
the link between hyperglycemia and GSH depletion. In-
deed, in hyperglycemic condition, glucose is preferen-
tially used in polyol pathway which consumes NADPH
necessary for GSH regeneration by the GSH-Reductase
enzyme. Hyperglycemia is therefore indirectly the cause
of GSH depletion. As GSH is an important antioxidant
molecule, its depletion leads to the increased of oxida-
tive stress.
The phytoconstituents responsible for the antihyper-
glycemic effects of Tecomella undulata includes flava-
noids, alkaloids, diterpenes, amino acid derivatives and
steroidal. Antihyperglycemic effect of Tecomella undu-
lata in both acute and chronic hyperglycemia may be
attributed to increased insulin secretion and improved
insulin action (decrease insulin resistance. This study
supported previous results by showing improved glucose
tolerance, reduced glycosylated hemoglobin and total
cholesterol in diabetic rats. Effectiveness of Tecomellan STZ induced diabetic rats
ose concentration (mg/dl) ± S.E.M
10th day 20th day 30th day
395.7 ± 7.6 373 ± 6.7 284± 7.2
251 ± 8.9*** 206.8 ± 7.9*** 123± 5.2***
285± 8.6** 275 ± 7.8** 237 ± 9.9**
263.9 ± 21.3 245 ± 23.5** 185± 9.5**
ed by Dunnett’s t test, * p< 0.05, ** p< 0.01, *** p< 0.001 vs. control; TU Eth.:
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sulin secreting properties of its alkaloid and terpenes
contents.
Conclusion
The present study demonstrated that the ethanolic
extract of Tecomella undulata leaves has potential anti-
hyperglycemic and antioxidant activity in STZ diabetic
rats. The mechanism of action of antihyperglycemic
action may involve improved insulin secretion or periph-
eral glucose utilization. Further, phytochemical and
pharmacological evaluations have to be carried on the
Tecomella undulata extract in order to identify the ac-
tive principles responsible for antihyperglycemic activity
and its mechanism.
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